F and FDR are used for regionalchemotherapy of celorectal liver metastases. Therapeutic concepts are differing concerning time and dosage of drug exposure. We determined the optimal concentration x time products for F, FR, and FDR to find out the most active anabolite, compared with the mother substance. HT-29 was incubated with the drugs at various times and concentrations.
The drug effect was determined by measuring the extent and duration of growth delay in soft agar culture medium. Incubation periods were 5min = 24h and doses ranged between .01 and 1000 pg/ml. The cultures were evaluated on day 6 after seeding to calculate inhibition of growth, and on days 18 and 20 to check for regrewth. In all experiments, there was a clear dose response with significant differences in toxicity within the 3 test substances. FR was the most active drug regarding cytostatic (growth delay) and cytotoxic (duration of growth delay, lack of regrowth) activity, followed by F and FDR (1h-24h exposure: FR> 9 F> FDR; ~20min exposure: FR~> FDR 9 F). There was a resistant subpopu!ation to FDR. -The differences became more pronounced at increasing doses. . A marked dose response was seen in 4/6 human solid tumors. In the cell lines, response was induced between .01 -0.1 pg/ml, in the human tumor biopsies in the range of 1 pg/ml. This dose range can be clinically achieved by hepatic-and bronchial artery infusions, and intraperitoneal instillations.
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